Global Human Insulin Market Overview: 2023-2028
Base Year: 2022
Historical Years: 2018-21
Forecast Years: 2023-2028
The Global Human Insulin Market is projected to grow at a CAGR of around 5.4% during the forecast period, i.e., 2023-28.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/human-insulin-market.html
Global Human Insulin Market Dynamics: 2023-2028
Global Human Insulin Market Key Drivers:
Surging Prevalence of Diabetes and Increased Insulin Product Launches - Diabetes cases are dramatically rising due to obesity and a sedentary lifestyle. Additionally, diabetes now affects all age groups, expanding the need for treatment and care. Moreover, the significant number of new product launches and higher utilization of insulin is further pushing the market forward. Major participants are introducing numerous new products, and manufacturers focus on creating unique products, driving industrial growth. For instance,
- In May 2022, Eli Lilly and Company got approved for their Mounjaro injection, which helps Type 2 diabetes patients improve their glycemic control.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/human-insulin-market.html
Global Human Insulin Market (2023-30): Segmentation Outlook
The market report has segmented the market into the following categories:
By Product Type
-Human Insulin Drugs
-Insulin Analogs Biosimilars
-Long Acting Biosimilars
-Rapid Acting Biosimilars
-Premixed Biosimilars
-Human Insulin Biologics
Short Acting Biologics
-Intermediate Acting Biologics
-Premixed Biologics
-Human Insulin Delivery Devices
-Syringes
-Pens
-Disposable Pens
-Reusable Pens
-Pen Needles
-Standard Pen Needles
-Safety Pen Needles
By Application
-Type I Diabetes
-Type II Diabetes
By Region
-North America
-South America
-Europe
-The Middle East Africa
-Asia-Pacific.
Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Global Human Insulin Market:
- Braun (B. Braun Melsungen), Becton, Dickinson and Company (BD), Biocon Limited, Biodel Inc., Eli Lilly and Company, Julphar (Gulf Pharmaceutical Industry), Novo Nordisk A/S, Sanofi, Wockhardt Ltd., The Ypsomed Group, Others.
Market Recent Developments
- In December 2022, Novo Nordisk A/S and Amalgam Rx announced their partnership for the commercialization of Dose Check, a digital insulin initiation and titration app by Amalgam Rx to help people with type 2 diabetes.
- In December 2022, Eli Lilly and Company announced a collaboration with Eva Pharma to deliver a sustainable supply of affordable human and analog insulin to one million people living with type 1 and type 2 diabetes in low to middle-income countries (LMICs).
Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.
Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
